The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors

被引:0
|
作者
J Caramel
S Medjkane
F Quignon
O Delattre
机构
[1] Institut Curie,
[2] Research Section,undefined
[3] INSERM U830,undefined
[4] Unité de Génétique et Biologie des Cancers,undefined
[5] 3Current address: Transcription Laboratory,undefined
[6] Cancer Research UK—London Research Institute,undefined
[7] 44 Lincoln's Inn Fields,undefined
[8] London WC2A 3PX,undefined
[9] UK.,undefined
来源
Oncogene | 2008年 / 27卷
关键词
SNF5/INI1; rhabdoid tumor suppressor; differentiation; SWI/SNF; adipocyte;
D O I
暂无
中图分类号
学科分类号
摘要
ATP-dependent SWI/SNF chromatin remodeling complexes regulate cell-cycle and play critical roles in a variety of differentiation pathways. The core subunit SNF5/INI1 is a tumor suppressor that is inactivated in a highly aggressive childhood cancer of unknown cellular origin, termed malignant rhabdoid tumor (MRT). The highly undifferentiated phenotype of this tumor suggests that the loss-of-function of hSNF5/INI1 impairs specific differentiation programs of the MRT parental cell. Based on the hypothesis that these programs might be reinitialized upon hSNF5/INI1 re-expression in MRTs, we show that some MRT cell lines can differentiate toward the adipogenic lineage. We further show that the knock down of the SNF5/INI1 subunit abrogates adipocyte differentiation of murine 3T3-L1 preadipocytes and of human mesenchymal stem cells. Finally, we provide evidence that hSNF5/INI1 cooperates with C/EBPβ and PPARγ2 transcriptional regulators to activate the expression of adipocyte-specific genes. These data indicate that not only the ATPase subunit of the SWI/SNF complex, but also SNF5/INI1 is required for adipocyte differentiation. They further show that MRT cell lines harbor an adipogenic differentiation potential and that the tumor suppressor role of the SNF5/INI1 subunit may rely on its ability to regulate the balance between cell proliferation and differentiation.
引用
收藏
页码:2035 / 2044
页数:9
相关论文
共 49 条
  • [1] The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors
    Caramel, J.
    Medjkane, S.
    Quignon, F.
    Delattre, O.
    ONCOGENE, 2008, 27 (14) : 2035 - 2044
  • [2] SNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors
    Rousseau-Merck, MF
    Versteege, I
    Legrand, I
    Couturier, J
    Mairal, A
    Delattre, O
    Aurias, A
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 130 - 130
  • [3] Familial occurrence of schwannomatosis and malignant rhabdoid tumor associated with a duplication in SNF5/INI1/SMARCB1
    Williams, M.
    Keyser, J.
    Swensen, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 195 - 195
  • [4] Loss of NOXA expression by INI1/SNF5 loss impaired sensitivity to chemotherapeutic agents in malignant rhabdoid tumor in vitro and iv vivo
    Ouchi, Kazutaka
    Kuwahara, Yasumichi
    Lehara, Tomoko
    Konishi, Eiichi
    Hosoi, Hajime
    CANCER RESEARCH, 2015, 75
  • [5] Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice
    Roberts, CWM
    Galusha, SA
    McMenamin, ME
    Fletcher, CDM
    Orkin, SH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (25) : 13796 - 13800
  • [6] Inhibition of early steps of HIV-1 replication by SNF5/Ini1
    Maroun, Marlene
    Delelis, Olivier
    Coadou, Gael
    Bader, Thomas
    Segeral, Emmanuel
    Mbemba, Gladys
    Petit, Caroline
    Sonigo, Pierre
    Rain, Jean-Christophe
    Mouscadet, Jean-Francois
    Benarous, Richard
    Emiliani, Stephane
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (32) : 22736 - 22743
  • [7] Rhabdoid tumor predisposition without mutation of SMARCB1 (SNF5/INI1) in a family:: Evidence for a second genomic locus
    Fruehwald, M. C.
    Juergens, H.
    Siebert, R.
    Hasselblatt, M.
    Schneppenheim, R.
    NEURO-ONCOLOGY, 2007, 9 (02) : 187 - 187
  • [8] Analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid rhabdoid tumors and a fraction of primitive neuroectodermal tumors without rhabdoid phenotype
    Haberler, C.
    Laggner, U.
    Slavc, Irene
    Czech, Thomas
    Budka, Herbert
    Hainfellner, Johannes A.
    NEURO-ONCOLOGY, 2007, 9 (02) : 187 - 187
  • [9] Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype
    Haberler, Christine
    Laggner, Ute
    Slavc, Irene
    Czech, Thomas
    Ambros, Inge M.
    Ambros, Peter F.
    Budka, Herbert
    Hainfellner, Johannes A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (11) : 1462 - 1468
  • [10] Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors
    Uno, K
    Takita, J
    Yokomori, K
    Tanaka, Y
    Ohta, S
    Shimada, H
    Gilles, FH
    Sugita, K
    Abe, S
    Sako, M
    Hashizume, K
    Hayashi, Y
    GENES CHROMOSOMES & CANCER, 2002, 34 (01): : 33 - 41